Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
567-04-005 ISMRM Abstract

Selective Vulnerability of Left Fimbria in Cognitively Normal APOE ε4 Carriers: A Neuroimaging Signature of Preclinical AD

Primary: Neuro - Alzheimer's Disease
Secondary: Neuro - Dementia
567-04-005 · Quantitative and Multimodal MRI Biomarkers Across Neurologic and Systemic Disorders · Wednesday, 13 May, 2:35 PM–3:30 PM · Digital Posters Row H
Keywords: Alzheimer's Disease Magnetic Resonance Imaging (MRI) APOE4 Hippocampal subfields atrophy
Accepted
Yihan Suo 1, Luoyu Wang2, Yuanyuan Zhao1, Qi Feng3, Zhongxiang Ding3
1The Fourth School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, China
2School of Biomedical Engineering, ShanghaiTech University, Shanghai, China
3Hangzhou First People's Hospital, Hangzhou, China
Presenting Author: Yihan Suo

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of alzheimer’s disease in late onset families. Science. 1993;261(5123):921–923. doi:10.1126/science.8346443 [doi]
2. Zhao W, Wang X, Yin C, He M, Li S, Han Y. Trajectories of the Hippocampal Subfields Atrophy in the Alzheimer’s Disease: A Structural Imaging Study. Front Neuroinformatics. 2019;13:13. doi:10.3389/fninf.2019.00013 [doi]
3. Evans TE, Adams HHH, Licher S, et al. Subregional volumes of the hippocampus in relation to cognitive function and risk of dementia. NeuroImage. 2018;178:129–135. doi:10.1016/j.neuroimage.2018.05.041 [doi]
4. Zammit AR, Ezzati A, Zimmerman ME, Lipton RB, Lipton ML, Katz MJ. Roles of hippocampal subfields in verbal and visual episodic memory. Behav Brain Res. 2017;317:157–162. doi:10.1016/j.bbr.2016.09.038 [doi]
5. Tamnes CK, Walhovd KB, Engvig A, et al. Regional hippocampal volumes and development predict learning and memory. Dev Neurosci. 2014;36(3-4):161–174. doi:10.1159/000362445 [doi]
6. Feng Q, Zhang Z, Dai F, et al. Volumetric alterations of hippocampal and amygdala subfields in azheimer’s disease. BMC Med Imaging. 2025;25(1): 378. doi:10.1186/s12880-025-01923-7 [doi]
7. Wadhwani AR, Affaneh A, Van Gulden S, Kessler JA. Neuronal apolipoprotein E4 increases cell death and phosphorylated tau release in alzheimer disease. Ann Neurol. 2019;85(5):726–739. doi:10.1002/ana.25455 [doi]
8. Hou TT, Han YD, Cong L, et al. Apolipoprotein E Facilitates Amyloid-β Oligomer-Induced Tau Phosphorylation. J Alzheimers Dis. 2020;74(2):521–534. doi:10.3233/JAD-190711 [doi]
9. Montagne A, Nation DA, Sagare AP, et al. APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline. Nature. 2020;581(7806):71–76.oi: 10.1038/s41586-020-2247-3. [doi]

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/567-04-005